American Century Companies’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.31M Buy
6,204
+3,487
+128% +$1.04M ﹤0.01% 2153
2026
Q1
$702K Buy
+2,717
New +$723K ﹤0.01% 2432
2024
Q4
– Sell
-1,099
Closed -$200K – 2922
2024
Q3
$200K Buy
+1,099
New +$212K ﹤0.01% 2759
2023
Q3
– Sell
-2,440
Closed -$286K – 2873
2023
Q2
$286K Buy
+2,440
New +$249K ﹤0.01% 2408

Other funds holding KRYS

American Century Companies's KRYS Position: Q2 2026 in Review

American Century Companies increased its Krystal Biotech (KRYS) stake by 128% in Q2 2026, buying an estimated $1.04M and bringing the position to 6,204 shares worth $2.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2153.

American Century Companies first reported a position in KRYS in Q2 2023 and has held it in 4 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • American Century Companies held 6,204 shares of Krystal Biotech worth $2.31M as of Q2 2026.
  • American Century Companies bought 3,487 Krystal Biotech shares in Q2 2026, an estimated $1.04M.
  • Krystal Biotech made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2153 holding.
  • American Century Companies first reported a position in Krystal Biotech in Q2 2023 and has held it in 4 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.